Webster’s Bristol Hospice buys Companion Hospice

This transaction represents Bristol Hospice’s seventeenth overall acquisition by the Bristol platform in partnership with Webster Equity Partners.

Bristol Hospice, backed by Webster Equity Partners, has acquired Companion Hospice, which provides end-of-life care services to more than 600 active patients daily in Southern California.

PRESS RELEASE

Salt Lake City, Utah (January 5th, 2021) – Bristol Hospice, a portfolio company of Webster Equity Partners, is pleased to announce the acquisition of the Companion Hospice (“Companion”) operations in the Southern California area. Companion delivers hospice and palliative care services to over 600 active patients daily in Southern California and is among one of the largest independent providers in the market.

Mike Uranga, CEO of Companion Hospice remarked that, “Our calling has always been to help others. That is the reason I founded this organization 26 years ago. It is apparent that Bristol Hospice shares our mission to Enhance the Quality of Life.  I am confident that our California Team Members and our patients will benefit from becoming a part of the Bristol family of companies.  Our hospice care teams in Southern California remain dedicated to providing exceptional patient care as they continue serving in their local communities under Bristol Hospice. Our outstanding staff will continue to place patient care first. Bristol Hospice is well-known to share in this commitment to quality care standards alongside many years of hospice experience.”

Bristol Hospice CEO, Hyrum Kirton, noted that, “Companion has been known for their dedication and drive towards superior patient care.  Bristol Hospice shares this focus through quality driven standards of care, the Bristol Hospice Foundation, and specialty care programs like Bright Moments and Sweet Dreams. The addition of Companion will give us access to provide comprehensive coverage to all hospice beneficiaries in Southern California. We look forward to continue building upon an existing legacy of excellent care with a stellar team of professionals, while living the Bristol mission of Embracing a Reverence for Life.”

This transaction represents Bristol Hospice’s seventeenth overall acquisition by the Bristol platform in partnership with Webster Equity Partners. Webster invested in Bristol Hospice in November 2017 with the goal of providing the highest quality care hospice and palliative care services to meet the physical, psychosocial and spiritual needs of individuals at the end of life.

About Bristol Hospice

Bristol Hospice began operations in 2006 and is headquartered in Salt Lake City, Utah. Bristol has a long history of providing exceptional hospice care across the country. With this most recent acquisition Bristol now operates 35 locations across 10 states including: AZ, CA, OR, HI, UT, CO, TX, GA, NV and FL. The Bristol Programs are designed to promote quality and comprehensive hospice services to patients and families in the communities they serve. The Bristol leadership is committed to the company’s vision and mission in the delivery of our hospice services. The Company holds firm to its values and mission – Embracing a Reverence for Life. For additional information on Bristol please visit www.bristolhospice.com.

About Webster Equity Partners

Founded in 2003, Webster Equity invests in healthcare services companies with high impact growth strategies that deliver the highest quality care and extraordinary service. Webster is currently investing out of its fourth fund with $875 million of committed capital. For additional information on Webster Equity Partners, please visit www.websterequitypartners.com.